نتائج البحث - "90Y ibritumomab tiuxetan"

1

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

المصدر: Leukemia & Lymphoma. 63:93-100

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Long term follow up, business.industry, Incidence (epidemiology), Follicular lymphoma, Phases of clinical research, Hematology, medicine.disease, Gastroenterology, Oncology, Internal medicine, medicine, 90Y ibritumomab tiuxetan, Rituximab, Cumulative incidence, In patient, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b867e6ca4e75601562d336212afa41f0Test
https://doi.org/10.1080/10428194.2021.1971216Test

2

A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

المصدر: LEUKEMIA & LYMPHOMA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

مصطلحات موضوعية: 90Y ibritumomab tiuxetan, 90Y ibritumomab tiuxetan, Follicular lymphoma, maintenance, Follicular lymphoma, maintenance

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b64a3d520daac0111273a2996543fd52Test
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10714Test

3

Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma

المؤلفون: Joseph D. Rosenblatt, Izidore S. Lossos, Isildinha M. Reis, Juan Pablo Alderuccio

المصدر: Leukemia & Lymphoma. 61:3234-3238

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Marginal zone lymphoma, Hematology, Radiation therapy, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Localized disease, Long term outcomes, medicine, 90Y ibritumomab tiuxetan, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2c8f391c52bfdb284457d8c9c60297eeTest
https://doi.org/10.1080/10428194.2020.1802449Test

4

دورية أكاديمية

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

المؤلفون: Ibatici, Adalberto, Pica, Gian Matteo, Nati, Sandro, Vitolo, Umberto, Botto, Barbara, Ciochetto, Chiara, Petrini, Mario, Galimberti, Sara, Ciabatti, Elena, Orciuolo, Enrico, Zinzani, Pier Luigi, Cascavilla, Nicola, Guolo, Fabio, Fraternali Orcioni, Giulio, Carella, Angelo M.

المساهمون: Ibatici, Adalberto, Pica, Gian Matteo, Nati, Sandro, Vitolo, Umberto, Botto, Barbara, Ciochetto, Chiara, Petrini, Mario, Galimberti, Sara, Ciabatti, Elena, Orciuolo, Enrico, Zinzani, Pier Luigi, Cascavilla, Nicola, Guolo, Fabio, Fraternali Orcioni, Giulio, Carella, Angelo M.

مصطلحات موضوعية: follicular lymphoma, (90Y)-Ibritumomab-Tiuxetan, high complete remission rate

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24344981; info:eu-repo/semantics/altIdentifier/wos/WOS:000331354700012; volume:164; issue:5; firstpage:710; lastpage:716; numberofpages:7; journal:BRITISH JOURNAL OF HAEMATOLOGY; https://hdl.handle.net/11568/527870Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84894081969

الإتاحة: https://doi.org/10.1111/bjh.12695Test
https://hdl.handle.net/11568/527870Test

View record in BASE

5

Positron Emission Tomography/Computed Tomography before Treatment as a Predictor of 90Y-Ibritumomab Tiuxetan Response

المؤلفون: Yukiko Arisaka, Yusri Dwi Heryanto, Azusa Tokue, Sayaka Kodaira, Norifumi Tsukamoto, Ryan Yudistiro, Tetsuya Higuchi, Akihiko Yokohama, Takuma Ishizaki, Hiroshi Handa, Yoshito Tsushima, Hiromi Koiso, Ayako Taketomi-Takahashi

المصدر: The Kitakanto Medical Journal. 68:151-156

مصطلحات موضوعية: business.industry, Radioimmunotherapy, medicine.medical_treatment, medicine, Ibritumomab tiuxetan, 90Y ibritumomab tiuxetan, Fdg pet ct, General Medicine, Nuclear medicine, business, medicine.drug, Positron Emission Tomography-Computed Tomography

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4f3647fa6a7cfbe08ab628749ad4b7e7Test
https://doi.org/10.2974/kmj.68.151Test

6

(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study

المؤلفون: Michele Cavo, Ginevra Lolli, Matteo Carella, Vittorio Stefoni, Alessandro Broccoli, Cinzia Pellegrini, Pier Luigi Zinzani, Alice Morigi, Miriam Marangon, Laura Nanni, Lisa Argnani, Beatrice Casadei

المساهمون: Lolli, Ginevra, Argnani, Lisa, Broccoli, Alessandro, Marangon, Miriam, Pellegrini, Cinzia, Morigi, Alice, Casadei, Beatrice, Nanni, Laura, Stefoni, Vittorio, Carella, Matteo, Cavo, Michele, Zinzani, Pier L

مصطلحات موضوعية: business.industry, treatment-naïve, Ibritumomab tiuxetan, 90Y-ibritumomab tiuxetan, MALT lymphoma, Hematology, medicine.disease, extra-nodal marginal zone B-cell lymphoma, Therapy naive, relapsed, Cancer research, medicine, 90Y ibritumomab tiuxetan, In patient, Extra nodal, Marginal zone B-cell lymphoma, business, Mucosa-associated lymphoid tissue, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6253012582febe15cd26765124bb32dfTest
http://hdl.handle.net/11585/804692Test

7

دورية أكاديمية

Les anticorps monoclonaux en hématologie en 2009 ; Monoclonal antibodies in hematology in 2009

المؤلفون: Bonnet, Christophe, Beguin, Yves, De Prijck, Bernard, Witvrouw, Nancy, Hustinx, Roland, Fillet, Georges

المصدر: Revue Médicale de Liège, 64, 268-273 (2009)

مصطلحات موضوعية: NHL, CLL, Rituximab, 90Y ibritumomab tiuxetan, Alemtuzumab, LNH, LLC, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

العلاقة: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/25411Test; info:hdl:2268/25411; https://orbi.uliege.be/bitstream/2268/25411/1/252.pdfTest; scopus-id:2-s2.0-67749095003; info:pmid:19642457

الإتاحة: https://orbi.uliege.be/handle/2268/25411Test
https://orbi.uliege.be/bitstream/2268/25411/1/252.pdfTest

View record in BASE

8

دورية أكاديمية

Les anticorps monoclonaux en hématologie en 2009
Monoclonal antibodies in hematology in 2009

المؤلفون: Bonnet, Christophe, Beguin, Yves, De Prijck, Bernard, Witvrouw, Nancy, Hustinx, Roland, Fillet, Georges

المصدر: Revue Médicale de Liège, 64, 268-273 (2009)

مصطلحات موضوعية: NHL, CLL, Rituximab, 90Y ibritumomab tiuxetan, Alemtuzumab, LNH, LLC, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

العلاقة: urn:issn:0370-629X; urn:issn:2566-1566

الوصول الحر: https://orbi.uliege.be/handle/2268/25411Test

View record in ORBi

9

Consolidation with (90)Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up

المؤلفون: Alicja M. Gruszka, Katarzyna Krawczyk, Dagmara Zimowska-Curylo, Anna Staszczak, Wojciech Jurczak, Pier Luigi Zinzani, Tomasz Wróbel, Monika Długosz-Danecka, Elżbieta Kisiel, Michal Szymczyk, Alicja Hubalewska-Dydejczyk, Agnieszka Giza, Aleksander B. Skotnicki, Malgorzata Jakobczyk, Marta Szostek, Wanda Knopinska-Posluszny

المساهمون: Jurczak, Wojciech, Gruszka, Alicja M, Sowa Staszczak, Anna, Dlugosz-Danecka, Monika, Szostek, Marta, Zimowska-Curylo, Dagmara, Giza, Agnieszka, Krawczyk, Katarzyna, Jakobczyk, Malgorzata, Hubalewska-Dydejczyk, Alicja, Szymczyk, Michal, Wróbel, Tomasz, Knopińska-Posłuszny, Wanda, Kisiel, Elżbieta, Skotnicki, Aleksander, Zinzani, Pier Luigi

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4734ee7a0298069746d60c5c5aab8f6cTest
http://hdl.handle.net/11585/738120Test

10

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

المؤلفون: Brad S. Kahl, Andres Forero-Torres, Sandra J. Horning, Leo I. Gordon, Fangxin Hong, Ranjana H. Advani, Hailun Li, Randy D. Gascoyne, Elisabeth Paietta, Mitchell R. Smith

المصدر: Leukemia. 31:517-519

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4c83ec8f2c3a9c1ab882d148b5a028cdTest
https://doi.org/10.1038/leu.2016.305Test

تنقيح النتائج